$AMRN
AMARIN CORP PLC\UK

2012 Q2 Form 10-Q Financial Statement

#000119312512344051 Filed on August 08, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2011 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $13.64M $10.03M
YoY Change 36.01% 258.04%
% of Gross Profit
Research & Development $14.07M $5.189M
YoY Change 171.07% -33.47%
% of Gross Profit
Depreciation & Amortization $50.00K $10.00K
YoY Change 400.0% 0.0%
% of Gross Profit
Operating Expenses $27.70M $15.21M
YoY Change 82.08% 43.53%
Operating Profit -$27.70M -$15.21M
YoY Change 82.08%
Interest Expense -$4.317M -$94.00K
YoY Change 4492.55% -99.69%
% of Operating Profit
Other Income/Expense, Net -$52.00K -$11.00K
YoY Change 372.73% -98.63%
Pretax Income -$51.00M $200.5M
YoY Change -125.44% -585.39%
Income Tax $2.904M -$1.635M
% Of Pretax Income -0.82%
Net Earnings -$53.90M -$202.1M
YoY Change -73.33% 388.68%
Net Earnings / Revenue
Basic Earnings Per Share -$0.38 -$1.58
Diluted Earnings Per Share -$0.38 -$1.58
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q2 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $250.3M $131.4M
YoY Change 90.49% 248.54%
Cash & Equivalents $250.3M $131.4M
Short-Term Investments
Other Short-Term Assets $6.433M $1.100M
YoY Change 484.82% 175.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $257.2M $132.6M
YoY Change 93.98% 243.52%
LONG-TERM ASSETS
Property, Plant & Equipment $621.0K $100.0K
YoY Change 521.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.482M $2.900M
YoY Change -14.41%
Total Long-Term Assets $13.95M $2.900M
YoY Change 381.17% 2800.0%
TOTAL ASSETS
Total Short-Term Assets $257.2M $132.6M
Total Long-Term Assets $13.95M $2.900M
Total Assets $271.2M $135.5M
YoY Change 100.13% 250.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.429M $1.900M
YoY Change 343.63% -50.0%
Accrued Expenses $9.100M $1.800M
YoY Change 405.56% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.50M $3.800M
YoY Change 360.5% -35.59%
LONG-TERM LIABILITIES
Long-Term Debt $127.4M $500.0K
YoY Change 25387.6%
Other Long-Term Liabilities $704.0K $286.0M
YoY Change -99.75% 95233.33%
Total Long-Term Liabilities $128.1M $286.5M
YoY Change -55.27% 95400.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.50M $3.800M
Total Long-Term Liabilities $128.1M $286.5M
Total Liabilities $265.9M $290.2M
YoY Change -8.39% 4657.38%
SHAREHOLDERS EQUITY
Retained Earnings -$710.6M
YoY Change
Common Stock $716.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $217.0K
YoY Change
Treasury Stock Shares 20.08K shares
Shareholders Equity $5.320M -$154.7M
YoY Change
Total Liabilities & Shareholders Equity $271.2M $135.5M
YoY Change 100.13% 250.13%

Cashflow Statement

Concept 2012 Q2 2011 Q2
OPERATING ACTIVITIES
Net Income -$53.90M -$202.1M
YoY Change -73.33% 388.68%
Depreciation, Depletion And Amortization $50.00K $10.00K
YoY Change 400.0% 0.0%
Cash From Operating Activities -$21.38M -$10.78M
YoY Change 98.33% 30.98%
INVESTING ACTIVITIES
Capital Expenditures -$170.0K -$10.00K
YoY Change 1600.0%
Acquisitions
YoY Change
Other Investing Activities -$830.0K $0.00
YoY Change
Cash From Investing Activities -$1.000M -$10.00K
YoY Change 9900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.81M 12.75M
YoY Change 110.27% 755.7%
NET CHANGE
Cash From Operating Activities -21.38M -10.78M
Cash From Investing Activities -1.000M -10.00K
Cash From Financing Activities 26.81M 12.75M
Net Change In Cash 4.430M 1.960M
YoY Change 126.02% -129.08%
FREE CASH FLOW
Cash From Operating Activities -$21.38M -$10.78M
Capital Expenditures -$170.0K -$10.00K
Free Cash Flow -$21.21M -$10.77M
YoY Change 96.94% 30.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 amrn Debt Instrument Redemption Price
DebtInstrumentRedemptionPrice
1.00 pure
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
-154715000
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131446000
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
533000
CY2012Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
593341000
CY2012Q2 us-gaap Purchase Obligation
PurchaseObligation
35300000
CY2012Q2 us-gaap Other Assets Current
OtherAssetsCurrent
6433000
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2482000
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
5320000
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
20079 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148112474 shares
CY2012Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11292993 shares
CY2012Q2 us-gaap Liabilities
Liabilities
265855000
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8429000
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
704000
CY2012Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
10851000
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-710648000
CY2012Q2 us-gaap Assets
Assets
271175000
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
271175000
CY2012Q2 us-gaap Treasury Stock Value
TreasuryStockValue
217000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
250255000
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
148132553 shares
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17499000
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
122844000
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2012Q2 us-gaap Assets Current
AssetsCurrent
257221000
CY2012Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
120214000
CY2012Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.44
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
621000
CY2012Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
127438000
CY2012Q2 amrn Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
9070000
CY2012Q2 amrn Excess Fair Value Over Principal Value
ExcessFairValueOverPrincipalValue
96100000
CY2012Q2 amrn Common Stock Volume Weighted Average Trading Price
CommonStockVolumeWeightedAverageTradingPrice
14.46
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-202367000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31442000
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
533000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
449393000
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1837000
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2241000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-5962000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20079 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
135812463 shares
CY2011Q4 us-gaap Liabilities
Liabilities
132341000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4419000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
764000
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4734000
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-568459000
CY2011Q4 us-gaap Assets
Assets
126379000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
126379000
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
217000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116602000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135832542 shares
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8452000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
98654000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-88000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3360000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1061000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
113321000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2011Q4 us-gaap Assets Current
AssetsCurrent
118972000
CY2011Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
123125000
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
432000
CY2011Q4 amrn Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4033000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22389000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-2303000
us-gaap Share Based Compensation
ShareBasedCompensation
3360000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-535000
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
1061000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.46
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2164647 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
32000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4954000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19586000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9000
us-gaap Income Taxes Paid
IncomeTaxesPaid
410000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
98654000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
100004000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4954000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
14930000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
182223000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9638000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
119599000
us-gaap Operating Expenses
OperatingExpenses
22389000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-95000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1061000
us-gaap Revenues
Revenues
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
707000
us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
108458000
us-gaap Interest Paid
InterestPaid
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
125907000 shares
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
44000
us-gaap Net Income Loss
NetIncomeLoss
183809000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12751000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1586000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-160017000
amrn Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
14930000
amrn Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
108458000
amrn Stock Issued During Period Of Stock And Warrants For Services Or Claims
StockIssuedDuringPeriodOfStockAndWarrantsForServicesOrClaims
44000
amrn Increase Decrease In Lease Related Liabilities
IncreaseDecreaseInLeaseRelatedLiabilities
-50000
amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
5000000
amrn Proceeds From Warrant Exercises Gross
ProceedsFromWarrantExercisesGross
15200000
amrn Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
10330642 shares
dei Trading Symbol
TradingSymbol
AMRN
dei Entity Registrant Name
EntityRegistrantName
AMARIN CORP PLC\UK
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000897448
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Operating Income Loss
OperatingIncomeLoss
-46484000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
14505000
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0035 pure
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8709000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
7960000
us-gaap Share Based Compensation
ShareBasedCompensation
8709000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4596000
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
7960000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.03
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2485647 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
75000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6678000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39122000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1089000
us-gaap Income Taxes Paid
IncomeTaxesPaid
313000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
264000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
133653000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
7960000
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.97 pure
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6020000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6678000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
825000
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P2Y3M18D
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
14930000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
139875000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18822000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
173864000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2508000
us-gaap Operating Expenses
OperatingExpenses
46484000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
8268000
us-gaap Revenues
Revenues
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
5533000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
20000
us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
92282000
us-gaap Interest Paid
InterestPaid
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138280000 shares
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
14000
us-gaap Net Income Loss
NetIncomeLoss
142189000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27662000
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
200468000
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5189000
CY2011Q2 us-gaap Operating Expenses
OperatingExpenses
15214000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
144316000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2314000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-85139000
amrn Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
14930000
amrn Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
92282000
amrn Stock Issued During Period Of Stock And Warrants For Services Or Claims
StockIssuedDuringPeriodOfStockAndWarrantsForServicesOrClaims
14000
amrn Increase Decrease In Lease Related Liabilities
IncreaseDecreaseInLeaseRelatedLiabilities
-46000
amrn Adjustments To Additional Paid In Capital Resulting From Conversion Of Convertible Debt Into Equity
AdjustmentsToAdditionalPaidInCapitalResultingFromConversionOfConvertibleDebtIntoEquity
22898000
amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
6670000
amrn Proceeds From Warrant Exercises Gross
ProceedsFromWarrantExercisesGross
14960000
amrn Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
9812622 shares
CY2011Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
98700000
CY2011Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
13800000 shares
CY2011Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
7.60
CY2011Q1 amrn Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
104900000
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15214000
CY2011Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.58
CY2011Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1169898 shares
CY2011Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3200000
CY2011Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
8500000
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
140550000 shares
CY2011Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-94000
CY2011Q2 us-gaap Revenues
Revenues
CY2011Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
128360000 shares
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
202103000
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10025000
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1635000
CY2011Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-185359000
CY2011Q2 amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
3300000
CY2011Q2 amrn Proceeds From Warrant Exercises Gross
ProceedsFromWarrantExercisesGross
8600000
CY2011Q2 amrn Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
5773278 shares
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27701000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.38
CY2012Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1931388 shares
CY2012Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5900000
CY2012Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
14870000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
51000000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14066000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
27701000
CY2012Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4317000
CY2012Q2 us-gaap Revenues
Revenues
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
53904000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13635000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2904000
CY2012Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-18930000
CY2012Q2 amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
5880000
CY2012Q2 amrn Proceeds From Warrant Exercises Gross
ProceedsFromWarrantExercisesGross
14900000
CY2012Q2 amrn Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
9772622 shares

Files In Submission

Name View Source Status
0001193125-12-344051-index-headers.html Edgar Link pending
0001193125-12-344051-index.html Edgar Link pending
0001193125-12-344051.txt Edgar Link pending
0001193125-12-344051-xbrl.zip Edgar Link pending
amrn-20120630.xml Edgar Link completed
amrn-20120630.xsd Edgar Link pending
amrn-20120630_cal.xml Edgar Link unprocessable
amrn-20120630_def.xml Edgar Link unprocessable
amrn-20120630_lab.xml Edgar Link unprocessable
amrn-20120630_pre.xml Edgar Link unprocessable
d361109d10q.htm Edgar Link pending
d361109dex101.htm Edgar Link pending
d361109dex102.htm Edgar Link pending
d361109dex103.htm Edgar Link pending
d361109dex104.htm Edgar Link pending
d361109dex105.htm Edgar Link pending
d361109dex106.htm Edgar Link pending
d361109dex311.htm Edgar Link pending
d361109dex312.htm Edgar Link pending
d361109dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending